Quantitative translational neuroscience: Bridging preclinical and human neuroscience research

Therapies for neuropsychiatric and neurodevelopmental disorders often fail to make the transition from successful preclinical trials to real world efficacy. This is for a large part due to the lack of good animal models for these diseases, which often target uniquely human cognitive and neural processes. These problems are especially prevalent in…